What is it about?

Hemoglobinopathies are the most common inherited diseases in humans resulting from impaired globin chain synthesis of hemoglobin. The progression of thalassemia rates is prevented with prenatal screening methods. This study aimed to retrospectively evaluate the hematological parameters of α- and β-thalassemia and normal fetuses aged 17-25 weeks of gestation. Pregnant women who underwent cordocentesis in the second trimester because of the risk of having a baby with thalassemia were included in the study.

Featured Image

Why is it important?

This study could be a good reference for future studies and prenatal diagnostic applications in emphasizing the importance of changes in the blood parameters of fetuses before molecular genotyping. These hematological data give valuable information to clinicians about the fetus to enlighten families in making appropriate decisions during prenatal diagnosis. The investigated hematological parameters are useful for the differentiation of thalassemias midpregnancy.

Read the Original

This page is a summary of: Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy, Balkan Medical Journal, July 2023, Journal of Clinical Research of Pediatric Endocrinology,
DOI: 10.4274/balkanmedj.galenos.2023.2023-1-86.
You can read the full text:

Read

Contributors

The following have contributed to this page